title: Prevention of heart failure.
abstract: OBJECTIVE
  Chronic heart failure imposes a significant health burden and remains a substantial and increasing problem despite advances in therapy. Hence, prevention of heart failure is a priority.
  
  
  RESULTS
  Various risk factors have been identified that contribute to the development of heart failure. In this review, we will discuss the various recently reported clinical trials, epidemiological studies, meta-analyses, and subanalyses that have identified these risk factors and have provided evidence regarding the strategies to prevent heart failure.
  
  
  CONCLUSIONS
  Heart failure is a costly, disabling, and potentially fatal disease. It is therefore important to incorporate the strategies for prevention of heart failure on the basis of the current available evidence into routine clinical practice.
authors.affiliation: Division of Cardiovascular Medicine, Department of Internal Medicine, University of Arkansas for Medical Sciences, Arkansas, USA.
authors.forename: Darpan
authors.initials: D
authors.lastname: Bansal
authors.forename: Georges
authors.initials: G
authors.lastname: Chahoud
authors.forename: Eugene S
authors.initials: ES
authors.lastname: Smith
authors.forename: Jawahar L
authors.initials: JL
authors.lastname: Mehta
mesh_terms: D050197:Atherosclerosis / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D002303:Cardiac Output, Low / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D048909:Diabetes Complications / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D016021:Epidemiologic Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D015201:Meta-Analysis as Topic; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D009765:Obesity / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D012307:Risk Factors